A detailed history of Elefante Mark B transactions in Johnson & Johnson stock. As of the latest transaction made, Elefante Mark B holds 18,738 shares of JNJ stock, worth $2.9 Million. This represents 2.47% of its overall portfolio holdings.

Number of Shares
18,738
Previous 6,180 203.2%
Holding current value
$2.9 Million
Previous $869,000 311739.93%
% of portfolio
2.47%
Previous 2.94%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$143.34 - $165.86 $1.8 Million - $2.08 Million
12,558 Added 203.2%
18,738 $2.71 Billion
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $65,049 - $78,532
505 Added 8.9%
6,180 $869,000
Q1 2020

May 07, 2020

BUY
$111.14 - $153.99 $630,719 - $873,893
5,675 New
5,675 $745,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Elefante Mark B Portfolio

Follow Elefante Mark B and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elefante Mark B, based on Form 13F filings with the SEC.

News

Stay updated on Elefante Mark B with notifications on news.